MP52-16 ANDROGEN DEPRIVATION THERAPY INCREASED THE RISK OF PULMOMARY EMBOLISM IN PATIENT WITH PROSTATE CANCER - FROM 24,464 PATIENTS, TAIWAN NATIONAL HEALTH INSURANCE RESEARCH DATABASE | Zendy

AI Assistant Blog Pricing

MP52-16 ANDROGEN DEPRIVATION THERAPY INCREASED THE RISK OF PULMOMARY EMBOLISM IN PATIENT WITH PROSTATE CANCER - FROM 24,464 PATIENTS, TAIWAN NATIONAL HEALTH INSURANCE RESEARCH DATABASE

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.